The bleeding with antithrombotic therapy study 2: Rationale, design, and baseline characteristics of the participants.

This study is expected to provide the incidence of bleeding complications of recent oral antithrombotics in clinical practice and identify their associations with underlying small vessel disease and other biomarkers. Novel risk stratification models for bleeding risk will be able to be created based on the study results.